{"ticker": {"uuid": "70e197ae-683e-4f73-99da-e5d2398291c1", "symbol": "4884", "name": "Kringle Pharma, Inc.", "exchange": "JPX", "country": "JP", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Kringle Pharma\u2019s phase II ALS study falls short", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxORDlZVW40TWZqQmY5QmR3Z2dhSnlOd21tSk56dWQ4TUpkUGM3czFwVEFOcGU1RG93RUpfYm1ETnRvTUVEUzRKQ0RQR2x4alFtcWNWMXpXS2xHUTJmWHQ4UDZvYUNXcXUybFl0eEx0U0tLQzludm5sWGZXVm1YX2U4TEdWYnhjTWtkaE5hTDgtaUg?oc=5", "source_name": "BioWorld News", "published_at": "2022-08-16T07:00:00+00:00", "published_display": "16 Aug 2022 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Kringle Pharma\u2019s phase II ALS study falls short", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxORDlZVW40TWZqQmY5QmR3Z2dhSnlOd21tSk56dWQ4TUpkUGM3czFwVEFOcGU1RG93RUpfYm1ETnRvTUVEUzRKQ0RQR2x4alFtcWNWMXpXS2xHUTJmWHQ4UDZvYUNXcXUybFl0eEx0U0tLQzludm5sWGZXVm1YX2U4TEdWYnhjTWtkaE5hTDgtaUg?oc=5", "source_name": "BioWorld News", "published_at": "2022-08-16T07:00:00+00:00", "published_display": "16 Aug 2022 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 61, "total_relevant": 1, "sentiment_summary": {"positive": 0, "negative": 1, "neutral": 0, "score": 34, "total": 1, "label": "Cautious news tone", "tone": "negative"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 72, "events": [{"event": "general", "label": "Market update", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 310.0, "latest_week": "2026-06-19", "one_week_move": 2.3, "four_week_move": -29.2, "twelve_week_move": -21.5, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.64598, "market_dynamics_buy_signal": false, "relative_strength": -52.951793, "fair_value_gap": -54.3, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 49.5968, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+2.3% over one week, -29.2% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Bad news being absorbed", "tone": "positive", "classification": "negative_absorbed", "summary": "Cautious headlines are being absorbed by price, which can signal underlying demand.", "confidence": 74, "badges": ["Caution agrees with inactive trend"], "opportunities": [], "risks": ["Negative tone is aligned with an inactive trend backdrop."], "event_label": "Market update", "sentiment_word": "cautious"}, "charts": {"sources": [{"label": "BioWorld News", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 1}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "34/100", "tone": "negative", "text": "Cautious news tone"}, {"label": "Market reaction", "value": "Bad news being absorbed", "tone": "positive", "text": "Cautious headlines are being absorbed by price, which can signal underlying demand."}, {"label": "Primary event", "value": "Market update", "tone": "negative", "text": "72/100 classification confidence."}, {"label": "Company focus", "value": "1", "tone": "neutral", "text": "directly relevant article"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+2.3% over one week, -29.2% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Negative", "tone": "negative", "text": "Kringle Pharma\u2019s phase II ALS study falls short"}], "updated_at": "2026-06-22T16:56:26.597896+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}